Although semaglutide has lost its exclusivity
2026-11-04 18:11:59
According to CoinMeta, Novo Nordisk's CEO stated that although semaglutide has lost its exclusivity, its performance in Canada is still quite good.
Bullish 0
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.